Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038698 | SCV000062376 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Thr728Ala in Exon 22 of NEBL: This variant is not expected to have clinical si gnificance because it has been identified in 7.5% (9/120) of chromosomes from a population in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP; rs71 535732). |
Gene |
RCV000038698 | SCV000170741 | benign | not specified | 2013-11-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000038698 | SCV000227942 | benign | not specified | 2015-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000477652 | SCV000563546 | benign | Primary dilated cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621280 | SCV000739871 | benign | Cardiovascular phenotype | 2012-08-10 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038698 | SCV003928272 | likely benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004717926 | SCV005320505 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003974888 | SCV004798665 | benign | NEBL-related disorder | 2019-11-12 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |